Search Results for "M L Laboritories"
04:11 EDT 25th May 2013 | BioPortfolio
Original Source: ML Labs
ML Laboratories aims to become a significant European pharmaceutical business. ML's primary strategy is to market therapies for serious diseases, where the initial diagnosis and treatment is carried out in hospital and subsequent management takes place at home. ML's current portfolio includes dialysis, respiratory, anticancer, antiviral and pain management products. ML is a subsidiary of Milner Laboratories Limited, an enterprise personally funded by Manchester businessman Kevin Leech to enable it to bring...
Matching Channels
None
Matching News
None
Matching PubMed Articles
None
Search Whole site using Google
Loading
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
